ArticleIn vivo (Athens, Greece)

Hypofractionated Intensity-modulated Radiotherapy for Intermediate- and High-risk Prostate Cancer: A Retrospective Study.

Nobuteru Kubo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.